Health
SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question – The Lancet
Since the onset of the COVID-19 pandemic, SARS-CoV-2 vaccine development has progressedat an unprecedented rate, with recent phase 3 trial data offering the tantalising…
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.
Copyright © 2021 Elsevier Inc. except certain content provided by third parties.
Privacy Policy Terms and Conditions
Continue Reading
-
Noosa News22 hours agoMajor crash on Gateway Motorway snarls morning commute
-
Business24 hours agoUp 34% this year, can Challenger shares keep rising according to Macquarie?
-
Business20 hours agoThis ASX 200 mining stock is eyeing the lithium throne
-
Noosa News18 hours agoDriver arrested after life-threatening hit-and-run on outskirts of Ipswich, Queensland